MP Baran challenges new prescription drug restrictions

Independent MP Burhan Baran has submitted a parliamentary inquiry to Health Minister Adonis Georgiadis, raising concerns over new disease coding regulations in electronic prescriptions, which have led to medication access restrictions for many patients.

In his statement, MP Baran highlights that as of January 15, 2024, a new disease classification system based on the ICD-10 international standard was implemented in electronic prescriptions. According to IDIKA (E-Government Center for Social Security Services), this change aims to improve diagnosis documentation and enhance healthcare service quality. However, its implementation has resulted in significant challenges, particularly in medication prescription restrictions.

The new coding system imposes "filters" on drug prescriptions, preventing many patients from receiving necessary treatments. Doctors have reported that certain medications previously available for specific conditions are now restricted, unless the diagnosis precisely matches an approved code. This has led to widespread frustration, especially among patients with chronic or serious illnesses who now struggle to access their prescribed medications.

Additionally, health professionals have criticized the lack of training and preparation before the transition, stating that many are unclear on which codes allow certain prescriptions. The absence of a trial period has caused delays in patient care, forcing doctors to alter treatment plans due to regulatory limitations.

MP Baran’s Questions to the Health Minister:

1. What measures will the Ministry take to ensure that patients in need of specific medications are not excluded from treatment due to technical prescription restrictions?
2. Is there a plan to review and revise the new disease coding system to prevent patients from being denied essential medication?
3. Why was there no prior training or pilot phase for doctors before implementing the new system, to avoid the current disruptions?
4. The parliamentary inquiry calls for urgent action to protect patients' rights to essential medications and address the flaws in the new prescription system.

Source: Empros News